3rd In Vivo Cell Engineering & Gene Editing Summit

Welcome to the 𝟯𝗿𝗱 𝗜𝗻 𝗩𝗶𝘃𝗼 𝗖𝗲𝗹𝗹 𝗘𝗻𝗴𝗶𝗻𝗲𝗲𝗿𝗶𝗻𝗴 & 𝗚𝗲𝗻𝗲 𝗘𝗱𝗶𝘁𝗶𝗻𝗴 𝗦𝘂𝗺𝗺𝗶𝘁! As promising pre-clinical and proof of concept results continue to emerge, the pivotal shift from the ‘dream’ of in vivo cell engineering and gene editing is rapidly becoming a reality as numerous companies push towards the clinic. 𝗨𝗻𝗶𝘁𝗶𝗻𝗴 𝗸𝗲𝘆 𝘁𝗵𝗼𝘂𝗴𝗵𝘁-𝗹𝗲𝗮𝗱𝗶𝗻𝗴 𝗲𝘅𝗽𝗲𝗿𝘁𝘀, the 3rd In Vivo Cell Engineering & Gene Editing Summit will be a uniquely positioned, must-attend gathering, 𝗱𝗲𝗹𝘃𝗶𝗻𝗴 𝗶𝗻𝘁𝗼 𝗮𝗹𝗹 𝗳𝗮𝗰𝗲𝘁𝘀 𝗼𝗳 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝘁𝗼 𝘀𝗽𝗲𝗮𝗿𝗵𝗲𝗮𝗱 𝗶𝗻 𝘃𝗶𝘃𝗼 𝗮𝘀 𝘁𝗵𝗲 𝗳𝗿𝗼𝗻𝘁𝗶𝗲𝗿 𝗼𝗳 𝗰𝗲𝗹𝗹 𝗮𝗻𝗱 𝗴𝗲𝗻𝗲 𝘁𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀. This once-a-year meeting explores every aspect of in vivo cell and gene therapies, from selecting an appropriate animal model to discussing target specificity and unveiling strategies for advancing towards the clinic. Join 𝗖-𝗹𝗲𝘃𝗲𝗹 𝗲𝘅𝗲𝗰𝘂𝘁𝗶𝘃𝗲𝘀, 𝗩𝗣𝘀, and 𝗗𝗶𝗿𝗲𝗰𝘁𝗼𝗿𝘀 𝗶𝗻 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆, 𝗣𝗿𝗲-𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹, and 𝗧𝗿𝗮𝗻𝘀𝗹𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗳𝗶𝗲𝗹𝗱𝘀 developing in vivo cell engineering and gene editing pipelines, as they converge to showcase various approaches, crystalize ambiguity, and ultimately advance pipelines to the next stage. Crafted in collaboration with industry titans such as 𝗖𝗮𝗽𝘀𝘁𝗮𝗻 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀, 𝗘𝗱𝗶𝘁𝗮𝘀 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲, 𝗡𝗮𝗻𝗼𝗖𝗲𝗹𝗹 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀, 𝗖𝗮𝗿𝗶𝘀𝗺𝗮 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀, 𝗠𝘂𝘀𝘁𝗮𝗻𝗴 𝗕𝗶𝗼, 𝗶𝗘𝗖𝗨𝗥𝗘, and many others, our newly curated agenda for 2024 promises unparalleled insights. Download Full Agenda - https://ter.li/s0p8bf Join us this July to glean invaluable knowledge from our world-class speaker faculty, offering an exclusive dive into how experts plan to stay ahead of the curve and shape the future of cell and gene therapy in the years ahead. Secure Your Place - https://ter.li/n8rlu4

Event Links

Website: https://go.evvnt.com/2291382-0

Tickets: https://go.evvnt.com/2291382-2

Brochure: https://go.evvnt.com/2291382-3

Read More

View Less